Pneumococcal Disease
Prevnar Voted for Inclusion in Vaccines for Children Program
Published in TB and Outbreaks Week, July 4th, 2000
Based on this vote all VFC-eligible children up to age five will have access to Prevnar. This significantly expands the market for Prevnar as 60% of all infants born in the U.S. are eligible for VFC and will substantially increase the public health impact of the vaccine.
The VFC is intended to increase childhood immunization levels by providing federally purchased vaccines to children who are enrolled in Medicaid, have no health insurance, are underinsured, or who are American Indian or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Diagnostics
Alternative Hybridization Assay Detects Mycobacterial Diseases - AIDS Therapies
World AIDS Series: Hit HIV-1 Hard, But Only When Necessary - Coinfection
Interferon-(alpha)2b and Ribavirin Evaluated in HCV/HIV Infected Patients - Group A Streptococcal Disease
Chickenpox Vaccination Could Prevent Invasive GAS Disease - Immunology
Interleukin-10 Causes Anergy in Tuberculosis Patients - Malaria
Genetic Mutations Increase Susceptibility to Severe Disease - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
